SJF-0628

N/A

Report date: 2022/05/25 11:23:46
NME

Base Information

Drug NameSJF-0628
Drug Alias NameSJF-0628
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)Small molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesYale University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A